These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19486940)

  • 1. Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift.
    Rigobello MP; Gandin V; Folda A; Rundlöf AK; Fernandes AP; Bindoli A; Marzano C; Björnstedt M
    Free Radic Biol Med; 2009 Sep; 47(6):710-21. PubMed ID: 19486940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of selenite and tellurite with thiol-dependent redox enzymes: Kinetics and mitochondrial implications.
    Rigobello MP; Folda A; Citta A; Scutari G; Gandin V; Fernandes AP; Rundlöf AK; Marzano C; Björnstedt M; Bindoli A
    Free Radic Biol Med; 2011 Jun; 50(11):1620-9. PubMed ID: 21397686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system.
    Jönsson-Videsäter K; Björkhem-Bergman L; Hossain A; Söderberg A; Eriksson LC; Paul C; Rosén A; Björnstedt M
    Biochem Pharmacol; 2004 Feb; 67(3):513-22. PubMed ID: 15037203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.
    Marzano C; Gandin V; Folda A; Scutari G; Bindoli A; Rigobello MP
    Free Radic Biol Med; 2007 Mar; 42(6):872-81. PubMed ID: 17320769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system.
    Selenius M; Fernandes AP; Brodin O; Björnstedt M; Rundlöf AK
    Biochem Pharmacol; 2008 Jun; 75(11):2092-9. PubMed ID: 18405881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A; Berggren M; Gasdaska JR; Powis G
    Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antioxidant Pycnogenol on cellular redox systems in U1285 human lung carcinoma cells.
    Gandin V; Nyström C; Rundlöf AK; Jönsson-Videsäter K; Schönlau F; Hörkkö J; Björnstedt M; Fernandes AP
    FEBS J; 2009 Jan; 276(2):532-40. PubMed ID: 19077163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of thioredoxin reductase activity in selenium-induced cytotoxicity.
    Madeja Z; Sroka J; Nyström C; Björkhem-Bergman L; Nordman T; Damdimopoulos A; Nalvarte I; Eriksson LC; Spyrou G; Olsson JM; Björnstedt M
    Biochem Pharmacol; 2005 Jun; 69(12):1765-72. PubMed ID: 15935149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
    Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arnér ES
    Free Radic Biol Med; 2009 Dec; 47(11):1661-71. PubMed ID: 19766715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia.
    Talbot S; Nelson R; Self WT
    Br J Pharmacol; 2008 Jul; 154(5):940-8. PubMed ID: 18587442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.
    Cox AG; Brown KK; Arner ES; Hampton MB
    Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing regulation of histamine-induced calcium signaling by sodium selenite and ebselen via alterations of thiol redox status.
    Zhang H; Zhong L
    Eur J Pharmacol; 2010 Jan; 626(2-3):276-82. PubMed ID: 19782065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
    Söderberg A; Sahaf B; Rosén A
    Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion.
    Gopalakrishna R; Chen ZH; Gundimeda U
    Arch Biochem Biophys; 1997 Dec; 348(1):37-48. PubMed ID: 9390172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning.
    Carvalho CM; Lu J; Zhang X; Arnér ES; Holmgren A
    FASEB J; 2011 Jan; 25(1):370-81. PubMed ID: 20810785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line.
    Zhong W; Oberley TD
    Cancer Res; 2001 Oct; 61(19):7071-8. PubMed ID: 11585738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of human ovarian tumor xenografts with selenite prevents the melphalan-induced development of drug resistance.
    Caffrey PB; Frenkel GD
    Anticancer Res; 1998; 18(4C):3017-20. PubMed ID: 9713502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
    Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
    Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.